Case Type: Mergers & Acquisitions

Velodyne Lidar, Inc. (VLDR), relating to its proposed merger with Ouster, Inc. Under the terms of the agreement, VLDR shareholders will receive 0.8204 shares of Ouster common stock per share they own.

Oyster Point Pharma, Inc. (OYST), relating to its proposed acquisition by Viatris Inc. Under the terms of the agreement, OYST shareholders will receive $11.00 in cash plus up to $2.00 per share in CVRs per share they own.

Opiant Pharmaceuticals, Inc. (OPNT), relating to its proposed acquisition by Indivior PLC. Under the terms of the agreement, OPNT shareholders will receive $20.00 in cash plus up to $8.00 per share in CVRs per share they own.

Luther Burbank Corp. (LBC), relating to its proposed acquisition by Washington Federal, Inc. Under the terms of the agreement, LBC shareholders will receive 0.3353 shares of Washington per share they own.

Washington Federal, Inc. (WAFD), relating to its proposed acquisition of Luther Burbank Corp.

Solid Biosciences, Inc. (SLDB), relating to its proposed merger with AavantiBio, Inc.

Benefitfocus, Inc. (BNFT), relating to its proposed acquisition by Voya Financial, Inc. Under the terms of the agreement, BNFT shareholders will receive $10.50 in cash per share they own.

SeaSpine Holdings Corp. (SPNE), relating to its proposed sale to Orthofix Medical Inc. Under the terms of the agreement, SeaSpine shareholders will own approximately 43.5% of the combined company

Atlas Corp. (ATCO), relating to its proposed sale to Poseidon Acquisition Corp. Under the terms of the agreement, ATCO shareholders will receive $15.50 in cash per share they own

ABIOMED, Inc. (ABMD), relating to its proposed acquisition by Johnson & Johnson. Under the terms of the tender offer, ABMD shareholders will receive $380.00 in cash per share they own.